Latest filing published 16 May 2018 for Aralez Pharmaceuticals Inc., €2,477.
Insider track record
Robert Paul Harris: trading record in brief
Robert Paul Harris appears in our data through filings on Aralez Pharmaceuticals Inc. shares, published by SEC (Form 4). Between 5 February 2016 and 11 May 2018, the trades on record add up to 9 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 16 May 2018 with an option exercise (€2,477) in Aralez Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Paul Harris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,500 shares@ CA$0.50270.2% of flowCommon SharesTSXSEDI:3184128
- 7,500 shares@ CA$1.41100.0% of flowCommon SharesTSXSEDI:3007643
- Common SharesTSXSEDI:2996734
- 20,000 shares@ CA$3.924.0% of flowCommon SharesTSXSEDI:2918708
- 104,778 shares@ CA$3.9221.0% of flowCommon SharesTSXSEDI:2918711
- 20,000 shares@ CA$4.654.7% of flowCommon SharesTSXSEDI:2918709
- 104,778 shares@ CA$4.992926.7% of flowCommon SharesTSXSEDI:2918713
- 75,000 shares@ CA$6.042922.3% of flowCommon SharesTSXSEDI:2892310
- 75,000 shares@ CA$5.6020.6% of flowCommon SharesTSXSEDI:2892303
9 of 9 declarations
